Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Subcommittee Hears Call For Medical Imaging Quality Standards

This article was originally published in The Gray Sheet

Executive Summary

At a House hearing July 18, the Medicare Payment Advisory Commission (MedPAC) and others urged Congress to mandate quality standards for providers who bill Medicare for diagnostic imaging services

You may also be interested in...



CMS Signals More Potential Cuts For Medicare Imaging Payments

CMS efforts to cut Medicare spending on imaging services are likely to continue in future payment policies

CMS Signals More Potential Cuts For Medicare Imaging Payments

CMS efforts to cut Medicare spending on imaging services are likely to continue in future payment policies

GE Exec Calls For New In Vitro Tests To Stratify Patients For Medical Imaging

New in vitro diagnostic tests are needed to ensure the most efficient use of costly investigative medical imaging procedures, according to a GE Healthcare exec

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023800

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel